Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:3520-3528, 2006
DOI: 10.2337/db06-0861
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rachdi, L.
Right arrow Articles by Bernal-Mizrachi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rachdi, L.
Right arrow Articles by Bernal-Mizrachi, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Effects of p27 in Regulation of ß-Cell Mass During Development, Neonatal Period, and Adult Life

Latif Rachdi1, Norman Balcazar1, Lynda Elghazi1, Daniel J. Barker1, Irina Krits1, Hiroaki Kiyokawa2, and Ernesto Bernal-Mizrachi1

1 Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, Missouri
2 Department of Molecular Pharmacology and Biological Chemistry, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Address correspondence and reprint requests to Ernesto Bernal-Mizrachi, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110. E-mail: ebernal{at}wustl.edu

Abbreviations: BrdU, bromodeoxyuridine; cdk, cyclin-dependent kinase; CKI, cell cycle inhibitor; INK4, inhibitor of kinase 4

ß-Cell cycle progression and proliferation are critical to maintain ß-cell mass in adult mice. Of the cell cycle inhibitors, p27Kip1 is thought to be the primary modulator of the proliferative status in most cell types. p27 plays a role in ß-cell adaptation in genetic models of insulin resistance. To study the role of p27 in ß-cells during physiological conditions and at different stages of ß-cell differentiation, we studied mice deficient of or overexpressing p27. Experiments in p27-deficient mice showed improved glucose tolerance and hyperinsulinemia. These changes were associated with increased islet mass and proliferation. The experiments overexpressing p27 in ß-cells were performed using a doxycycline-inducible model. Interestingly, overexpression of p27 for 16 weeks in ß-cells from adult mice had no effect on glucose tolerance, ß-cell mass, or proliferation. In contrast, induction of p27 expression during ß-cell development or early neonatal period resulted in severe glucose intolerance and reduced ß-cell mass by decreased proliferation. These changes were reversible upon discontinuation of doxycycline. These experiments suggest that p27 is a critical molecule for ß-cell proliferation during ß-cell development and early postnatal life but not for maintenance of adult mass.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
R. K. Gupta, N. Gao, R. K. Gorski, P. White, O. T. Hardy, K. Rafiq, J. E. Brestelli, G. Chen, C. J. Stoeckert Jr., and K. H. Kaestner
Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4{alpha}
Genes & Dev., April 1, 2007; 21(7): 756 - 769.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.